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Chronic kidney disease (CKD) is a major public health concern with rising
prevalence. Vitamin D deficiency (<20 ng/mL) and insufficiency (20–29 ng/mL) are
common among patients with CKD undergoing dialysis. The objective was to
review current research on vitamin D supplementation for dialysis patients and
the effect on their serum vitamin D levels.
There are two main forms of vitamin D found in foods, cholecalciferol and
ergocalciferol. Cholecalciferol (vitamin D3) is taken in the diet from fortified dairy
products and fish oils or is synthesized in the skin.1 The largest quantities of the
vitamin in food are found in fatty fish like swordfish, salmon, tuna, and sardines.1-2
The fortified foods include milk, yogurt, cheese, orange juice, breads and cereals.1-

The population studied were patients, ages 18 years old and up, with endstage renal disease undergoing dialysis. The sample size was 70 patients
with an effect size of 0.8. A similar study was used to determine sample
size.4 The G*power calculation was completed by using the mean vitamin D
levels from a similar study.

After 3 months, the serum 25(OH)D increased from 14.3 ± 4.7 ng/mL to
43.1 ± 11.0 ng/mL (p < 0.05) in the 50,000 IU cholecalciferol per week
group (n=30). The 10,000 IU per cholecalciferol per day group (n=40)
increased in serum 25(OH)D from 23.9 ± 4.2 ng/mL to 33.5 ± 4.3 ng/mL
(p<0.05). Results were statistically significant with p<0.05.

A major source of vitamin D is what is made in the body from the steroid 5,7cholestradienol, commonly called 7-dehydrocholesterol.2-3 This steroid is derived
from cholesterol.2

Further research is needed for the specific timeframe that vitamin D3
supplementation is beneficial for dialysis patients once normal serum
levels are achieved to maintain normal levels. Also, more research is
needed to determine adequate supplementation timeframe when
patients are taking supplements and increasing dietary vitamin D intake
and sunshine exposure.

The biologically active form of Vitamin D, 1,25(OH)2D3, affects calcium and
phosphorus homeostasis and has numerous other diverse physiological
functions.1 The active form of vitamin D is also called calcitriol.1
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